Analyses also Show that Combining a Threshold for ALT Reduction of ≥17 U/L with Normalization of Liver Fat Improves Predictive...
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease...
ORANGE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced a significant expansion...
Company will underscore the importance of rapid diagnostic technology for detecting bloodstream infections (BSIs) and sepsisLEXINGTON, Mass., June 21, 2021...
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next...
Dr. Valerie Montgomery Rice and Peter Taylor Join 23andMe’s Board as the Company Sets to Accelerate Personalized Healthcare Based on...
– CFT7455 Demonstrated High Binding Affinity to Cereblon and Target Selectivity in Non-Hodgkin’s Lymphoma Cell Models, Producing Rapid and Deep...
-First clinical data presented for ALG-010133, which is in development for S-antigen reduction in chronic hepatitis B (CHB) patients-Presentations include...
ORANGE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the expansion of...
SAN CARLOS, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a company focused on cellular and cell-derived therapeutics for...
Data presented at the 16th ICML Meeting demonstrate KT-413’s potent antitumor activity as a monotherapy compared to a clinically active...
NewYorkBIO and NYSE’s Emerging Biotech Company ShowcaseSpring European Virtual MidCap Event31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2021)Epigenetic...
SYDNEY, Australia, June 21, 2021 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE) (FSE:R9Q) (Company), the Company developing new classes of...
New analyses adds to the growing body of evidence for seladelpar’s potential as a treatment for patients with PBCNEWARK, Calif.,...
New analyses from the Phase 3 REGENERATE study highlight the relationship between early reductions of aminotransferases and fibrosis improvement in...
Sydney, AUSTRALIA, June 21, 2021 (GLOBE NEWSWIRE) -- Â Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or Company), is pleased to...
CX-2029 is the first CD71-targeting antibody-drug conjugate (ADC) administrated to patients, with a generally well-tolerated safety profile at doses that...
New Phase I clinical trial, called INSIGHT-003, in patients with various solid tumoursExpands the evaluation of efti into a triple...
Garner location becomes CarolinasDentist’s 10th office in North CarolinaGARNER, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- CarolinasDentist, a local dental...
Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDTCHARLOTTESVILLE, Va., June 21, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc....